Fernando J. Kim, MD, MBA, FACS, discusses internal physician factors and external factors in the current medical field that can put careers and patient safety at risk. He then reviews ways in which systems thinking and professionalism can optimize outcomes in urology practices.
Read More
Fernando J. Kim, MD, MBA, FACS, reviews the historical events contributing to the emergence of patient safety as a healthcare discipline. He describes efforts in the urologic field, specifically from the American Urological Association (AUA), to advance the culture of patient safety.
Read More
Sanjay G. Patel, MD, outlines the rationale behind implementing Enhanced Recovery After Surgery (ERAS) protocols in order to reduce stress, maintain postoperative physiology, and enhance mobilization for patients undergoing cystectomy. He then reviews the data evaluating different ERAS interventions in each perioperative period.
Read More
J. Kellogg Parsons, MD, MHS, FACS, reviews general principles of patient safety as applied to urologic practice. He provides practical instructions about handling urologic complications, specifically rhabdomyolysis, venous thromboembolism (VTE), air embolism, laparoscopic bowel injury, and prostate biopsy infections.
Read More
Sigrid V. Carlsson, MD, PhD, MPH discusses the psychology, history, and practical application of shared decision making. She then provides recommendations for clinicians counseling patients deciding whether or not to undergo PSA screening and if they should go on active surveillance.
Read More
Laila E. Woc-Colburn, MD, DTM&H, FACP, FIDSA, discusses the current scope of antibiotic resistance and risk factors for infectious complications in transrectal biopsy. She also reviews a questionnaire developed for assessing risk factors and the use of a rectal swab to direct antibiotic prophylaxis.
Read More
Larry I. Lipshultz, MD, provides an up-to-date definition of gender dysphoria and criteria for urologic transgender surgery. He also shares an interview with a patient prior to surgery and a review, in movie format, of an actual operative procedure.
Read More
Mohit Khera, MD, MBA, MPH, reviews the literature surrounding the safety of testosterone replacement therapy (TRT) following prostate cancer treatment, including after brachytherapy, EBRT, and radical prostatectomy (RP). He also discusses the concept of bipolar androgen therapy (BAT) and the importance of TRT for erectile preservation post-RP.
Read More
M. Scott Lucia, MD, led the “Next Generation in Biomarkers” session at the Future Directions in Urology Symposium (FDUS) 2018. These consensus statements represent a comprehensive analysis of current issues, challenges, and advancements in urology from a panel of international experts.
Read More
Mohit Khera, MD, MBA, MPH, led the “Next Generation General Urology and Men’s Health” session at the Future Directions in Urology Symposium (FDUS) 2018. These consensus statements represent a comprehensive analysis of current issues, challenges, and advancements in urology from a panel of international experts.
Read More
Daniel P. Petrylak, MD, led the “Next Generation Developments in GU Cancer” session at the Future Directions in Urology Symposium (FDUS) 2018. These consensus statements represent a comprehensive analysis of current issues, challenges, and advancements in urology from a panel of international experts.
Read More
Sam S. Chang, MD, MBA, and Michael S. Cookson, MD, led the “Next Generation Developments in Bladder Cancer” session at the Future Directions in Urology Symposium (FDUS) 2018. These consensus statements represent a comprehensive analysis of current issues, challenges, and advancements in urology from a panel of international experts.
Read More
